プロバイオティクスと健康に関するジャーナル
オープンアクセス

概要

Innovative Device-Based Therapies for Heart Failure: Advancing Care in Reduced Ejection Fraction

Rohit Mody1*, Shishir Kumar Roul2, Debabrata Dash3, Umanshi Dash1, Bhavya Mody4

Heart Failure (HF) remains a global health challenge despite advancements in Guideline-Directed Medical Therapy (GDMT). The high prevalence of morbidity and mortality necessitates novel treatment approaches. Recent innovations in device-based therapies provide new hope, particularly for HF with reduced Ejection Fraction (HFrEF). This study summarizes key device-based interventions in HF management, focusing on their mechanisms, clinical utility, and future directions.